0,953  0,001  Antimutagenic
0,951  0,002  Aldehyde oxidase inhibitor
0,916  0,003  Caspase 9 stimulant
0,914  0,002  UGT1A6 substrate
0,908  0,003  CYP1A2 inhibitor
0,905  0,002  CTGF expression inhibitor
0,903  0,001  Cystathionine beta-synthase inhibitor
0,893  0,003  NOS2 expression inhibitor
0,887  0,002  UGT1A9 substrate
0,860  0,005  TNF expression inhibitor
0,830  0,005  Aryl hydrocarbon receptor agonist
0,829  0,004  12-Lipoxygenase inhibitor
0,825  0,004  Free radical scavenger
0,823  0,002  UGT1A3 substrate
0,816  0,005  Chemoprotective
0,812  0,004  Antioxidant
0,822  0,014  Apoptosis agonist
0,812  0,005  15-Lipoxygenase inhibitor
0,806  0,004  AR expression inhibitor
0,804  0,003  Histamine release inhibitor
0,801  0,003  Sulfotransferase substrate
0,799  0,004  Amyloid beta aggregation inhibitor
0,791  0,003  UGT1A1 substrate
0,791  0,003  Genotoxic
0,775  0,011  Antineoplastic (breast cancer)
0,761  0,002  SULT1A3 substrate
0,756  0,002  UGT2B15 substrate
0,755  0,006  CYP1A2 substrate
0,751  0,005  Caspase 3 stimulant
0,740  0,002  Peroxidase inhibitor
0,739  0,004  Superoxide dismutase inhibitor
0,755  0,024  Alpha-glucosidase inhibitor
0,734  0,008  Chemopreventive
0,719  0,003  GABA C receptor rho-3 antagonist
0,727  0,015  Antineoplastic (lung cancer)
0,713  0,005  Lipoxygenase inhibitor
0,713  0,005  Cardioprotectant
0,707  0,004  Breast cancer-resistant protein inhibitor
0,720  0,018  Transcription factor NF kappa B inhibitor
0,692  0,005  UDP-glucuronosyltransferase substrate
0,701  0,014  Antineoplastic (colorectal cancer)
0,688  0,003  Amylase inhibitor
0,688  0,004  Monophenol monooxygenase inhibitor
0,692  0,014  Antineoplastic (colon cancer)
0,681  0,003  Melanin inhibitor
0,672  0,003  NADPH oxidase inhibitor
0,670  0,005  UGT1A4 substrate
0,673  0,012  Prostate cancer treatment
0,666  0,008  Antineoplastic (cervical cancer)
0,661  0,017  Antileukemic
0,646  0,004  Skin whitener
0,642  0,004  MAO A inhibitor
0,641  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,633  0,003  Xanthine oxidase inhibitor
0,634  0,006  Antiamyloidogenic
0,628  0,005  MAO inhibitor
0,631  0,009  NOS3 expression inhibitor
0,626  0,008  5 Hydroxytryptamine release inhibitor
0,626  0,010  Proliferative diseases treatment
0,622  0,007  Ulceration
0,617  0,004  Interleukin 4 antagonist
0,627  0,015  Antihypercholesterolemic
0,601  0,001  Creatine kinase inhibitor
0,603  0,005  Tubulin antagonist
0,609  0,011  Cytostatic
0,605  0,014  Radioprotector
0,596  0,005  P-glycoprotein inhibitor
0,588  0,002  GABA C receptor rho-2 antagonist
0,595  0,015  CYP2C19 substrate
0,623  0,047  Antiinflammatory
0,588  0,014  Antineoplastic (melanoma)
0,579  0,005  Antihypoxic
0,592  0,022  CYP2C9 substrate
0,575  0,011  CYP2C19 inhibitor
0,559  0,005  UGT2B4 substrate
0,565  0,014  CYP2C9 inhibitor
0,556  0,005  Pyruvate kinase inhibitor
0,559  0,011  Antiprotozoal (Leishmania)
0,555  0,008  Antineoplastic enhancer
0,561  0,017  Spasmolytic
0,546  0,003  Beta glucuronidase inhibitor
0,541  0,006  Antiseptic
0,547  0,014  Antineoplastic (non-small cell lung cancer)
0,543  0,011  Vasodilator, coronary
0,542  0,011  DNA damaging
0,533  0,003  CYP2B6 inhibitor
0,532  0,003  Carbonic anhydrase III inhibitor
0,530  0,002  VEGF expression inhibitor
0,543  0,018  Mutagenic
0,525  0,002  Antihelmintic (Trematoda)
0,526  0,010  Antineoplastic (osteosarcoma)
0,513  0,002  NAD(P)H dehydrogenase (quinone) inhibitor
0,513  0,004  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,521  0,016  Antineoplastic (glioma)
0,512  0,010  Antihypertriglyceridemic
0,514  0,015  Nitric oxide antagonist
0,501  0,003  Antihemorrhagic
0,499  0,007  Topoisomerase II inhibitor
0,511  0,019  Apoptosis antagonist
0,505  0,013  Tumour necrosis factor alpha release inhibitor
0,501  0,011  RNA-directed DNA polymerase inhibitor
0,512  0,022  Carcinogenic
0,504  0,019  Cardiovascular analeptic
0,488  0,005  Acetylcholinesterase inhibitor
0,502  0,019  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,507  0,026  Antineoplastic (ovarian cancer)
0,484  0,005  MAO B inhibitor
0,479  0,002  SULT1A1 substrate
0,474  0,005  NOS3 expression enhancer
0,466  0,004  Carbonic anhydrase VI inhibitor
0,480  0,017  Hypoglycemic
0,502  0,040  CYP3A4 substrate
0,467  0,005  Pneumotoxic
0,464  0,006  Lipid peroxidase inhibitor
0,462  0,007  Antihypotensive
0,490  0,036  Antipruritic, allergic
0,454  0,007  5 Hydroxytryptamine uptake stimulant
0,455  0,010  Cyclic AMP phosphodiesterase inhibitor
0,446  0,003  Nitric-oxide synthase stimulant
0,460  0,019  Antineoplastic (glioblastoma multiforme)
0,482  0,045  Prostaglandin dehydrogenase inhibitor
0,459  0,026  Antineoplastic (brain cancer)
0,437  0,004  Carbonic anhydrase XIII inhibitor
0,461  0,032  CYP2D6 substrate
0,445  0,017  Vasodilator
0,435  0,011  Dual specificity phosphatase inhibitor
0,458  0,035  5 Hydroxytryptamine release stimulant
0,464  0,043  Calcium channel L-type activator
0,425  0,004  Alpha tubulin antagonist
0,431  0,011  Hepatoprotectant
0,426  0,008  VCAM1 expression inhibitor
0,419  0,003  Gastritis treatment
0,434  0,019  Antimitotic
0,421  0,007  Antineoplastic (gastric cancer)
0,422  0,010  Antineoplastic (squamous cell carcinoma)
0,416  0,004  Topoisomerase II alpha inhibitor
0,437  0,030  Antineoplastic (pancreatic cancer)
0,420  0,014  Antineoplastic (sarcoma)
0,419  0,013  Antineoplastic (bladder cancer)
0,434  0,030  Antiosteoporotic
0,432  0,029  ICAM1 expression inhibitor
0,407  0,004  Carbonic anhydrase XV inhibitor
0,406  0,006  Tumour necrosis factor antagonist
0,439  0,039  Bone diseases treatment
0,402  0,004  Histidine decarboxylase inhibitor
0,427  0,033  Cytotoxic
0,397  0,005  Alkaline phosphatase inhibitor
0,400  0,009  DNA methyltransferase I inhibitor
0,415  0,024  Radiosensitizer
0,409  0,020  Vascular (periferal) disease treatment
0,447  0,058  Antibacterial
0,392  0,005  M18 aspartyl aminopeptidase inhibitor
0,397  0,010  Cholinergic
0,408  0,022  Antineoplastic (renal cancer)
0,408  0,022  Antineoplastic (liver cancer)
0,424  0,038  FMO1 substrate
0,404  0,019  Antineoplastic (small cell lung cancer)
0,393  0,009  Protein kinase stimulant
0,389  0,005  5-Lipoxygenase inhibitor
0,397  0,014  Dual specificity phosphatase 3 inhibitor
0,418  0,038  Hepatic disorders treatment
0,386  0,006  Chelator
0,447  0,070  Alzheimer's disease treatment
0,402  0,027  Antipyretic
0,404  0,032  Sensitization
0,375  0,004  LDLR expression enhancer
0,372  0,004  Estrogen receptor beta antagonist
0,374  0,014  Antineoplastic (carcinoma)
0,372  0,017  GST M1-1 substrate
0,369  0,015  UGT2B7 substrate
0,368  0,017  Non-steroidal antiinflammatory agent
0,355  0,005  Estrogen antagonist
0,350  0,004  Estrogen receptor alpha antagonist
0,375  0,030  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,353  0,009  Neurotrophic factor enhancer
0,358  0,015  DNA methylase inhibitor
0,346  0,008  Aldehyde dehydrogenase inhibitor
0,342  0,007  Gout treatment
0,339  0,004  Macrophage migration inhibitory factor inhibitor
0,339  0,004  Beta tubulin antagonist
0,334  0,003  Xanthine dehydrogenase inhibitor
0,367  0,038  Antineoplastic (multiple myeloma)
0,328  0,004  Multidrug resistance-associated protein 1 inhibitor
0,356  0,036  Cardiodepressant
0,337  0,023  Platelet adhesion inhibitor
0,318  0,004  Aldose reductase inhibitor
0,313  0,003  GABA C receptor rho-1 antagonist
0,327  0,017  Carcinogenic, group 3
0,324  0,015  Protein-tyrosine phosphatase inhibitor
0,316  0,008  Antiprotozoal (Coccidial)
0,311  0,004  Antineoplastic (uterine cancer)
0,347  0,041  Antiprotozoal (Trypanosoma)
0,320  0,013  Antidote
0,416  0,113  DNA polymerase beta inhibitor
0,305  0,003  Estradiol 17 beta-dehydrogenase inhibitor
0,338  0,036  Angiogenesis stimulant
0,340  0,039  Dyrk kinase inhibitor
0,309  0,009  Heat shock protein 90 antagonist
0,338  0,039  Transcription factor STAT inhibitor
0,377  0,079  Antiprotozoal
0,306  0,008  UGT2B1 substrate
0,310  0,012  Glutathione S-transferase substrate
0,305  0,010  Butyrylcholinesterase inhibitor
0,301  0,010  Antifungal enhancer
0,300  0,011  Topoisomerase I inhibitor
0,324  0,037  Antiparasitic
0,400  0,115  DNA directed DNA polymerase inhibitor
0,284  0,003  DOPA decarboxylase inhibitor
0,309  0,030  Antihelmintic
0,309  0,029  Tyrosine 3 hydroxylase inhibitor
0,323  0,044  Antidiabetic symptomatic
0,281  0,003  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,292  0,016  Heat shock protein 90 alpha antagonist
0,335  0,061  Respiratory analeptic
0,303  0,029  Antiviral (Influenza)
0,327  0,056  Teratogen
0,269  0,005  GABA C receptor antagonist
0,278  0,015  Succinate dehydrogenase inhibitor
0,283  0,021  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,269  0,007  Choleretic
0,266  0,006  HIV-1 integrase (3'-Processing) inhibitor
0,273  0,013  Protein kinase (CK2) alpha inhibitor
0,328  0,069  Antifungal
0,265  0,006  Estrogen agonist
0,267  0,009  UGT2B10 substrate
0,279  0,023  Amyloid beta precursor protein antagonist
0,261  0,006  Uric acid excretion stimulant
0,308  0,054  Insulysin inhibitor
0,279  0,027  Mcl-1 antagonist
0,299  0,048  Interleukin antagonist
0,253  0,006  Aromatase inhibitor
0,263  0,017  UGT2B9 substrate
0,260  0,015  Protein-tyrosine phosphatase 1B inhibitor
0,326  0,081  Angiogenesis inhibitor
0,285  0,040  5 Hydroxytryptamine 1E antagonist
0,245  0,006  Postmenopausal disorders treatment
0,245  0,007  HIV-1 integrase (Strand Transfer) inhibitor
0,285  0,049  Antineoplastic (lymphocytic leukemia)
0,310  0,075  Streptokinase A inhibitor
0,239  0,004  Carbonic anhydrase VII inhibitor
0,242  0,008  CF transmembrane conductance regulator agonist
0,255  0,020  Cyclooxygenase 1 inhibitor
0,240  0,005  Keratolytic
0,312  0,080  Calcium channel activator
0,250  0,018  Carcinogenic, group 1
0,306  0,074  CYP3A4 inhibitor
0,236  0,004  Cyclin B3 inhibitor
0,248  0,017  Alkylator
0,257  0,027  Interferon gamma antagonist
0,234  0,004  Myeloperoxidase inhibitor
0,234  0,004  SULT1E1 substrate
0,247  0,021  Antineoplastic (bone cancer)
0,252  0,026  Cyclooxygenase inhibitor
0,236  0,011  Mediator release inhibitor
0,228  0,003  D-Ala-D-Ala ligase inhibitor
0,235  0,012  Toll-Like receptor 2 antagonist
0,224  0,005  Heat shock protein 70 antagonist
0,226  0,006  Electron transport complex I inhibitor
0,230  0,011  Cyclooxygenase 3 inhibitor
0,281  0,064  Embryotoxic
0,225  0,009  Protein kinase C zeta inhibitor
0,232  0,020  Cholesterol synthesis inhibitor
0,306  0,096  Antiprotozoal (Plasmodium)
0,231  0,021  Antiviral (Ebola)
0,237  0,029  Antiviral (Influenza A)
0,218  0,010  Alcohol dehydrogenase inhibitor
0,211  0,005  Histone deacetylase SIRT1 stimulant
0,211  0,005  Histone deacetylase stimulant
0,223  0,017  Carcinogenic, group 2B
0,213  0,012  Dementia treatment
0,210  0,010  Phosphodiesterase 4D inhibitor
0,220  0,020  Antitussive
0,209  0,009  Papain-like protease (SARS coronavirus) inhibitor
0,324  0,124  Antiparkinsonian
0,283  0,086  Analeptic
0,206  0,012  Vascular dementia treatment
0,236  0,043  Insulin sensitizer
0,202  0,010  Urease inhibitor
0,237  0,045  I kappa B kinase epsilon inhibitor
0,207  0,020  Antibacterial (Helicobacter pylori)
0,199  0,014  Telomerase inhibitor
0,213  0,029  Neurotensin receptor agonist
0,188  0,004  Fatty acid synthase inhibitor
0,283  0,100  Antineoplastic (endocrine cancer)
0,211  0,028  Cyclooxygenase 2 inhibitor
0,294  0,114  GST A substrate
0,190  0,010  DNA repair enzyme inhibitor
0,200  0,020  Expectorant
0,196  0,017  Coagulant
0,186  0,008  CDC25A inhibitor
0,266  0,088  FMO3 substrate
0,246  0,068  Antineoplastic (lymphoma)
0,230  0,055  Abortion inducer
0,236  0,061  MAP kinase kinase 2 inhibitor
0,208  0,034  Bone formation stimulant
0,277  0,105  Antithrombotic
0,201  0,030  Mannose-6-phosphate isomerase inhibitor
0,247  0,076  Myocardial infarction treatment
0,179  0,009  Carbonic anhydrase V inhibitor
0,199  0,029  Psychosexual dysfunction treatment
0,278  0,109  Vasodilator, peripheral
0,203  0,034  ATPase inhibitor
0,174  0,005  Estrogen receptor beta agonist
0,185  0,017  Mucolytic
0,182  0,015  Chronic obstructive bronchitis treatment
0,272  0,105  Sodium/bile acid cotransporter inhibitor
0,181  0,014  AMP-activated protein kinase stimulant
0,174  0,008  UGT2B11 substrate
0,182  0,017  Photosensitizer
0,169  0,004  Topoisomerase II beta inhibitor
0,201  0,037  Antirickettsial
0,184  0,022  Protein kinase (CK2) inhibitor
0,199  0,038  Phobic disorders treatment
0,191  0,031  DNA polymerase I inhibitor
0,246  0,086  Transcription factor STAT3 inhibitor
0,170  0,012  Thioredoxin inhibitor
0,173  0,017  Antiviral (Influenza B)
0,226  0,071  Antiulcerative
0,162  0,009  Carbonic anhydrase VA inhibitor
0,157  0,003  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,154  0,003  Transcription factor RelA inhibitor
0,188  0,038  Hemostatic
0,182  0,033  Antihyperlipoproteinemic
0,305  0,158  Cyclophilin D inhibitor
0,305  0,158  Antidiabetic
0,190  0,043  Arachidonic acid antagonist
0,162  0,019  Androgen antagonist
0,250  0,108  Antimycobacterial
0,149  0,008  Antidote, heavy metal
0,188  0,048  Interleukin 6 antagonist
0,185  0,045  Hexokinase inhibitor
0,258  0,118  Thyroid hormone antagonist
0,160  0,021  Sphingomyelinase inhibitor
0,156  0,019  Transcription factor STAT6 inhibitor
0,168  0,032  GST P1-1 substrate
0,169  0,036  Adenylate cyclase stimulant
0,234  0,101  Antituberculosic
0,180  0,048  Insulin secretagoues
0,142  0,011  Thioredoxin reductase inhibitor
0,147  0,017  Antiviral (Coronavirus)
0,147  0,017  Antiviral (SARS coronavirus)
0,216  0,086  MAP-kinase-activated kinase 5 inhibitor
0,132  0,004  GABA B receptor antagonist
0,149  0,023  Phosphodiesterase IV inhibitor
0,141  0,014  Ornithine decarboxylase inhibitor
0,136  0,010  Carbonic anhydrase VB inhibitor
0,246  0,121  Thyroid hormone beta antagonist
0,164  0,039  Farnesoid X receptor antagonist
0,159  0,034  Beta amyloid protein antagonist
0,306  0,181  Antineoplastic (solid tumors)
0,153  0,030  Bronchodilator
0,128  0,006  Carbonic anhydrase XIV inhibitor
0,133  0,012  HIV-1 integrase inhibitor
0,127  0,006  Estrogen receptor alpha agonist
0,200  0,080  Psychostimulant
0,145  0,025  Antifungal (Pneumocystis)
0,181  0,061  Antihelmintic (Nematodes)
0,147  0,031  Antineoplastic antibiotic
0,123  0,007  Aryl hydrocarbon receptor antagonist
0,186  0,071  Antipruritic, non-allergic
0,141  0,026  Prolactin inhibitor
0,125  0,011  Neuraminidase (influenza) inhibitor
0,126  0,012  Granulocyte macrophage colony stimulating factor agonist
0,239  0,130  Antiallergic
0,160  0,051  Interleukin 1 antagonist
0,126  0,019  Dopamine D1 antagonist
0,148  0,041  Vanilloid 1 agonist
0,135  0,028  Arylamine N-Acetyltransferase substrate
0,190  0,084  Histone acetyltransferase inhibitor
0,142  0,037  TRPA1 agonist
0,215  0,111  Flavin-containing monooxygenase substrate
0,126  0,024  Interleukin 12 antagonist
0,120  0,018  Lipase inhibitor
0,122  0,022  Interleukin 5 antagonist
0,102  0,005  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,159  0,062  Antidiarrheal
0,109  0,013  Neuraminidase inhibitor
0,148  0,052  Antiprotozoal (Trichomonas)
0,210  0,114  Immunostimulant
0,109  0,014  Maillard reaction inhibitor
0,111  0,018  SULT1A2 substrate
0,099  0,006  Postcoital contraceptive
0,162  0,069  Antiviral (Herpes)
0,115  0,022  Glutamate decarboxylase inhibitor
0,097  0,005  Ryanodine receptor antagonist
0,112  0,020  Antiviral (Hepatitis A)
0,121  0,029  Antifungal (Aspergillus)
0,105  0,014  CDC25B inhibitor
0,152  0,062  Contraceptive
0,099  0,011  Glutamate (mGluR7) antagonist
0,136  0,049  DNA intercalator
0,093  0,007  DNA-dependent protein kinase inhibitor
0,164  0,078  Aldehyde oxidase substrate
0,142  0,056  Retinoprotector
0,097  0,012  Heat shock protein 90 beta antagonist
0,090  0,005  Dopamine D5 agonist
0,124  0,040  Toll-Like receptor 4 antagonist
0,134  0,050  Contraceptive female
0,283  0,199  MAP kinase 1 inhibitor
0,096  0,013  Cyclin B1 inhibitor
0,103  0,020  Leukotriene antagonist
0,200  0,117  Antiviral (West Nile virus)
0,092  0,010  Cyclin B2 inhibitor
0,105  0,024  Leukotriene synthesis inhibitor
0,131  0,050  Microtubule formation inhibitor
0,152  0,072  Phospholipase A2 inhibitor
0,084  0,004  Nucleoside transporters inhibitor
0,094  0,016  Protease activated receptor antagonist
0,223  0,146  Cholesterol antagonist
0,144  0,067  Cytokine production inhibitor
0,089  0,012  Cyclin D1 inhibitor
0,117  0,042  Anabolic
0,085  0,011  CD45 antagonist
0,083  0,010  Glucose-6-phosphate translocase inhibitor
0,102  0,031  mTOR complex 2 inhibitor
0,159  0,089  Phospholipase C inhibitor
0,073  0,004  Estrogen-related receptor beta antagonist
0,092  0,022  Anticholelithogenic
0,119  0,050  Alpha 2c adrenoreceptor antagonist
0,178  0,109  Antialcoholic
0,233  0,164  Immunosuppressant
0,071  0,004  ATP citrate lysase inhibitor
0,080  0,015  Cyclin B inhibitor
0,091  0,027  Phosphodiesterase VI inhibitor
0,125  0,062  Proteasome inhibitor
0,079  0,016  Leukotriene B4 antagonist
0,179  0,117  ErbB-1 antagonist
0,094  0,034  Estrogen-related receptor beta agonist
0,108  0,048  HIV-1 integrase (Overall Integration) inhibitor
0,154  0,096  Death-associated protein kinase 2 inhibitor
0,102  0,045  Actinic keratosis treatment
0,142  0,086  Eye irritation, high
0,138  0,082  Ca2+-transporting ATPase inhibitor
0,080  0,024  Beta 3 adrenoreceptor antagonist
0,062  0,006  Catechol O-methyltransferase inhibitor
0,088  0,033  Dopamine agonist
0,096  0,041  Glutathione S-transferase inhibitor
0,198  0,143  Antiischemic
0,134  0,081  Cell wall synthesis inhibitor
0,060  0,008  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,093  0,042  Vanilloid agonist
0,190  0,138  DNA synthesis inhibitor
0,221  0,170  Stroke treatment
0,062  0,011  Neuraminidase (Influenza A) inhibitor
0,130  0,079  Glycogen synthase kinase-3 alpha inhibitor
0,098  0,047  Aminoacyl-tRNA synthetase inhibitor
0,130  0,081  Neurotrophic factor
0,084  0,035  MAP kinase kinase 7 inhibitor
0,078  0,029  SULT2A1 substrate
0,104  0,058  Cyclin-dependent kinase 9 inhibitor
0,056  0,012  Arginase inhibitor
0,161  0,117  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,063  0,019  Vanilloid 2 antagonist
0,070  0,027  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,087  0,044  Na+ K+ transporting ATPase inhibitor
0,099  0,056  Potassium channel (Ca-activated) activator
0,059  0,019  Cholesterol esterase inhibitor
0,053  0,013  Estrogen-related receptor alpha antagonist
0,065  0,025  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,069  0,029  Alcohol oxidase inhibitor
0,127  0,088  CDC-like kinase 1 inhibitor
0,151  0,113  Antiviral (Hepatitis)
0,046  0,009  Protein kinase (CK2) beta inhibitor
0,082  0,044  Narcotic antagonist
0,079  0,044  GABA B receptor agonist
0,064  0,029  Phosphatidylinositol 3-kinase gamma inhibitor
0,068  0,034  Antimycoplasmal
0,096  0,061  Phosphodiesterase 6D inhibitor
0,085  0,050  T cell inhibitor
0,145  0,111  3C-like protease (Human coronavirus) inhibitor
0,058  0,025  Antibiotic Glycopeptide-like
0,064  0,031  Carbonic anhydrase XII inhibitor
0,070  0,038  Beta adrenoreceptor antagonist
0,056  0,024  Potassium channel Kv1.3 blocker
0,104  0,073  Endometrios treatment
0,048  0,019  DNA gyrase subunit A inhibitor
0,051  0,024  Dopamine D5 antagonist
0,077  0,050  Antitreponemal
0,087  0,061  NADH dehydrogenase inhibitor
0,121  0,095  Activin receptor-like kinase 2 inhibitor
0,092  0,067  Bile acid receptor antagonist
0,044  0,019  Cholesterol absorption inhibitor
0,092  0,069  Anticataract
0,098  0,075  Antiprotozoal (Toxoplasma)
0,126  0,104  Thrombolytic
0,105  0,085  Interleukin 8 antagonist
0,072  0,052  Cathepsin G inhibitor
0,085  0,066  ATPase (Vacuolar H+) inhibitor
0,112  0,095  Antiviral (Papilloma)
0,223  0,207  Transcription factor inhibitor
0,071  0,055  Antibiotic
0,027  0,012  Estrone sulfatase inhibitor
0,035  0,020  Melatonin 2 agonist
0,083  0,069  Antidote, mercury
0,087  0,072  ABCA1 expression enhancer
0,130  0,115  Uterine stimulant
0,079  0,065  Ca(v)3.1 blocker
0,078  0,065  Inducible nitric-oxide synthase inhibitor
0,078  0,065  Carcinogenic, group 2A
0,141  0,128  Catenin beta inhibitor
0,025  0,012  Monocarboxylic acid transporter inhibitor
0,025  0,012  Monocarboxylic acid transporter 1 inhibitor
0,025  0,013  Dopamine D1 agonist
0,110  0,098  Toll-Like receptor 9 antagonist
0,055  0,043  Leukotriene C antagonist
0,052  0,041  GABA receptor antagonist
0,094  0,083  Antihelmintic (Fasciola)
0,059  0,050  Nitric oxide donor
0,049  0,040  CXC chemokine 1 receptor antagonist
0,128  0,120  Muscular dystrophy treatment
0,047  0,040  Squalene epoxidase inhibitor
0,019  0,012  Antibiotic Anthracycline-like
0,099  0,093  Aldehyde dehydrogenase substrate
0,057  0,051  Transcription factor AP-1 inhibitor
0,034  0,028  Inosine monophosphate dehydrogenase inhibitor
0,023  0,017  Dopamine autoreceptor agonist
0,112  0,108  Antiischemic, cerebral
0,049  0,045  Protein kinase C eta inhibitor
0,039  0,035  Dopamine D2 agonist
0,054  0,050  Androgen agonist
0,110  0,107  Acaricide
0,057  0,054  Heme oxygenase stimulant
0,066  0,063  Alpha 2a adrenoreceptor antagonist
0,054  0,052  Sphingosine kinase inhibitor
0,115  0,113  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,083  0,081  Antiviral (Rhinovirus)
0,018  0,016  Inosine monophosphate dehydrogenase 2 inhibitor
0,036  0,034  Vanilloid 3 antagonist
0,066  0,065  CYP2A6 inhibitor
0,120  0,120  Muscle relaxant
0,080  0,080  Paget's disease treatment
0,088  0,088  Alpha 2b adrenoreceptor antagonist

